Anna Morra - Publications

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Journal: Cancer medicine

Published: February 21, 2023

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.

Journal: NPJ breast cancer

Published: November 13, 2022

The impact of coding germline variants on contralateral breast cancer risk and survival.

Journal: American journal of human genetics

Published: July 20, 2022

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.

Journal: JAMA oncology

Published: January 27, 2022

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

Journal: Breast cancer research : BCR

Published: February 16, 2021

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: June 17, 2020

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study.

Journal: BMC medicine

Published: May 15, 2020

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

Journal: British journal of cancer

Published: April 27, 2020